Several studies conducted in other oncological domains have demonstrated that the application of radiomics to advanced MRI sequences can yield substantial predictive capabilities regarding Ki-67 status, as evidenced by research in the context of gastrointestinal and breast cancer [36,37] . The gene discussed is MKI67; the disease is breast carcinoma.